缪云秋, 何淑芳, 梁金英, 柯琴, 张馨欣, 王瑞, 甘勇. 脂质-磷酸钙核/壳纳米粒作为抗肿瘤药物载体的初步研究J. 药学学报, 2017,52(6): 977-984. doi: 10.16438/j.0513-4870.2017-0052
引用本文: 缪云秋, 何淑芳, 梁金英, 柯琴, 张馨欣, 王瑞, 甘勇. 脂质-磷酸钙核/壳纳米粒作为抗肿瘤药物载体的初步研究J. 药学学报, 2017,52(6): 977-984. doi: 10.16438/j.0513-4870.2017-0052
MIAO Yun-qiu, HE Shu-fang, LIANG Jin-ying, KE Qin, ZHANG Xin-xin, WANG Rui, GAN Yong. Preliminary study of lipid bilayer-coated calcium phosphate nanoparticles as a drug carrier for antitumor drugJ. Acta Pharmaceutica Sinica, 2017,52(6): 977-984. doi: 10.16438/j.0513-4870.2017-0052
Citation: MIAO Yun-qiu, HE Shu-fang, LIANG Jin-ying, KE Qin, ZHANG Xin-xin, WANG Rui, GAN Yong. Preliminary study of lipid bilayer-coated calcium phosphate nanoparticles as a drug carrier for antitumor drugJ. Acta Pharmaceutica Sinica, 2017,52(6): 977-984. doi: 10.16438/j.0513-4870.2017-0052

脂质-磷酸钙核/壳纳米粒作为抗肿瘤药物载体的初步研究

Preliminary study of lipid bilayer-coated calcium phosphate nanoparticles as a drug carrier for antitumor drug

  • 摘要: 本文拟构建一种新型的脂质-磷酸钙核/壳纳米粒(lipid bilayer-coated calcium phosphate nanoparticles,LCAPNs)可在胞内溶解实现迅速释药,以提高抗肿瘤药物对肿瘤细胞的杀伤活性。采用薄膜分散法合成制备了包载紫杉醇(paclitaxel,PTX)的脂质-磷酸钙核/壳纳米粒(lipid bilayer-coated calcium phosphate nanoparticles loaded with PTX,PTX-LCAPNs),并对其进行形态、粒度和体外释放行为的表征。同时,以人肝癌细胞Huh-7为细胞模型,考察载体的细胞摄取、胞内溶解特性、药物胞内蓄积量和抗肿瘤活性。研究结果表明:LCAPNs在透射电镜下呈球形,平均粒径为124.73±6.41 nm。载体在体外模拟正常生理pH条件下PTX泄漏量低,而在胞内酸性pH环境中快速释药。另外,LCAPNs可有效提高Huh-7细胞对药物的摄取量,并且在胞内溶解以快速释药。PTX-LCAPNs显著增加PTX对肿瘤细胞的杀伤力,将包载紫杉醇的磷酸钙纳米粒(calcium phosphate nanoparticles loaded with PTX,PTX-CAPNs)的胞内药物浓度提高了1.7倍,半数抑制浓度(IC50)降低了约5倍,抗肿瘤效果显著增强。

     

    Abstract: This study aims to prepare lipid bilayer-coated calcium phosphate core-shell nanoparticles (LCAPNs), which can dissolve in an acidic environment to improve the tumor cell toxicity of antitumor drug. Paclitaxel (PTX) loaded lipid coated calcium phosphate nanoparticles (PTX-LCAPNs) were prepared by thin-film dispersion method. The morphology, particle size and in vitro release behavior were characterized. Meanwhile, the intracellular uptake, intracellular dissolution, cell toxicity of PTX-LCAPNs and intracellular accumulation of PTX were evaluated in human HCC cell line (Huh-7). The results suggested that the mean diameter of the spherical LCAPNs was 124.73±6.41 nm. The PTX-LCAPNs demonstrated little drug leakage in simulated normal physiological conditions, while a rapid release was observed in simulated intracellular condition in vitro. Moreover, the PTX-LCAPNs achieved 1.7 fold improvement in the intracellular PTX concentration leading to 5-fold reduction in half maximal inhibitory concentration (IC50) values of PTX compared with calcium phosphate nanoparticles loaded with PTX (PTX-CAPNs), demonstrating a stronger cancer cell lethality.

     

/

返回文章
返回